Inactive Instrument

Islet Holdings, Inc. Stock price Other OTC

Equities

ISHI

US46467L1026

Pharmaceuticals

Sales 2000 727K Sales 2001 637K Capitalization 15.25M
Net income 2000 -1M Net income 2001 -3M EV / Sales 2000 9.04 x
Net Debt 2000 287K Net cash position 2001 546K EV / Sales 2001 23.1 x
P/E ratio 2000
-5.66 x
P/E ratio 2001
-3.18 x
Employees -
Yield 2000 *
-
Yield 2001
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Islet Holdings Inc. is a biotechnology company, which is focused on cosmeceuticals. The Company is engaged in the research, development and commercialization of patented technologies in the field of transplantation in the therapy of people with conditions of insulin-dependent diabetes. The Company is developing intellectual property relating to hemp farming and extraction of cannabidiol (CBD) from hemp. Its technology constitutes methods for isolating, culturing, cryopreservation and immune-protection (microencapsulation) of islet cells. The Company's product candidates are intended for the treatment of insulin-dependent diabetes and are intended to be administered into the patient's abdominal cavity, where the transplanted islet cells will produce insulin in response to increase in blood glucose. The primary function of microencapsulation is to protect the islets from the host's immune system. The microcapsule coating is composed of layers of biocompatible materials.
More about the company
  1. Stock
  2. Equities
  3. Stock Islet Holdings, Inc.
  4. Stock Islet Holdings, Inc. - Other OTC